Neurology: Volume 91, Number 11, September 11, 2018 Exam #2 - Dual antiplatelet therapy pretreatment in IV thrombolysis for acute ischemic stroke
About this course
- Released: 9/11/2018
- Expires: 9/11/2021
DUAL ANTIPLATELET THERAPY PRETREATMENT IN IV THROMBOLYSIS FOR ACUTE ISCHEMIC STROKE
Upon completion of the article by Tsivgoulis et al, the participant should be able to:
- Describe how pretreatment with dual antiplatelet (DAP) therapy impacted the rate of various safety outcomes in patients treated with IV thrombolysis in this study
- Discuss how, after controlling for other confounders, DAP pretreatment was independently associated with various safety and efficacy outcomes following treatment with IV thrombolysis in this study
- Identify patient subgroups in study in whom DAP pretreatment was associated with an excess risk of various safety outcomes following IV thrombolytic treatment
The article by Tsivgoulis et al covers the following core competency:
- Medical Knowledge
Refer to listing above the references in each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
The American Academy of Neurology Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
AMA CREDIT DESIGNATION STATEMENT
The American Academy of Neurology Institute designates this journal-based-CME activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
James WM Owens Jr. MD, PhD receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology. Adam Kelly, MD, has served as a guest editor of Continuum (April 2014) and receives a stipend in his editorial capacity for Neurology.
This CME program receives no commercial support.